Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody)

NCT05453435 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Resolved Hepatitis B
CD20 Positive B-cell Lymphoma

Interventions

DRUG: Entecavir

Sponsor

Sun Yat-sen University